Bulletin
Investor Alert

ALX Oncology Holdings Inc.

NAS: ALXO

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
ALX Oncology Holdings Inc.

After Hours

 --Quotes are delayed by 20 min

Jan 21, 2022, 5:49 p.m.

ALXO
/zigman2/quotes/219511930/composite

$

15.50

Change

+0.06 +0.39%

Volume

Volume 143,785

Quotes are delayed by 20 min

/zigman2/quotes/219511930/composite

Previous close

$ 16.07

$ 15.44

Change

-0.63 -3.92%

Day low

Day high

$15.24

$16.39

Open

52 week low

52 week high

$15.24

$89.04

Open

Company Description

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indicati...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company's predecessor was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in Burlingame, CA.

Valuation

Price to Sales Ratio

2,905.75

Price to Book Ratio

7.99

Enterprise Value to EBITDA

-4.98

Efficiency

Revenue/Employee

51,391.00

Income Per Employee

-1,988,696.00

Receivables Turnover

4.41

Total Asset Turnover

0.01

Liquidity

Current Ratio

70.28

Quick Ratio

70.28

Cash Ratio

69.99

Profitability

Gross Margin

9.05

Operating Margin

-3,693.99

Pretax Margin

-3,849.32

Net Margin

-3,869.71

Return on Assets

-20.48

Return on Equity

-21.30

Return on Total Capital

-20.08

Return on Invested Capital

-21.03

Capital Structure

Officers and Executives

Name Age Officer Since Title
Dr. Jaume Pons 54 2015 President, Chief Executive Officer & Director
Dr. Michael Chang - 2015 Vice President-Operations
Mr. Peter S. García 58 2020 Chief Financial Officer
Dr. Sophia Randolph 52 2016 Chief Medical Officer
Mr. Hank Stern - 2015 Vice President-Chemistry, Manufacturing & Controls

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/15/2021 Sophia Randolph
Chief Medical Officer; Director 		11,059   Derivative/Non-derivative trans. at $1.91 per share. 21,122
12/15/2021 Sophia Randolph
Chief Medical Officer; Director 		12,793   Derivative/Non-derivative trans. at $0.99 per share. 12,665
12/13/2021 LSV CAPITAL MANAGEMENT LLC
60   Disposition at $30.23 per share. 1,813
12/13/2021 LSV CAPITAL MANAGEMENT LLC
440   Disposition at $30.23 per share. 13,301
12/13/2021 LSV CAPITAL MANAGEMENT LLC
181   Disposition at $29.6 per share. 5,357
12/13/2021 LSV CAPITAL MANAGEMENT LLC
1,329   Disposition at $29.6 per share. 39,338
12/13/2021 LSV CAPITAL MANAGEMENT LLC
299   Disposition at $28.37 per share. 8,482
12/13/2021 LSV CAPITAL MANAGEMENT LLC
2,196   Disposition at $28.37 per share. 62,300
12/13/2021 LSV CAPITAL MANAGEMENT LLC
1,296   Disposition at $27.49 per share. 35,627
12/13/2021 LSV CAPITAL MANAGEMENT LLC
9,509   Disposition at $27.49 per share. 261,402
12/13/2021 LSV CAPITAL MANAGEMENT LLC
2,339   Disposition at $26.48 per share. 61,936
12/13/2021 LSV CAPITAL MANAGEMENT LLC
17,169   Disposition at $26.48 per share. 454,635
12/13/2021 LSV CAPITAL MANAGEMENT LLC
1,627   Disposition at $25.29 per share. 41,146
12/13/2021 LSV CAPITAL MANAGEMENT LLC
11,945   Disposition at $25.29 per share. 302,089
12/13/2021 LSV CAPITAL MANAGEMENT LLC
60   Disposition at $30.23 per share. 1,813
12/13/2021 LSV CAPITAL MANAGEMENT LLC
440   Disposition at $30.23 per share. 13,301
12/13/2021 LSV CAPITAL MANAGEMENT LLC
181   Disposition at $29.6 per share. 5,357
12/13/2021 LSV CAPITAL MANAGEMENT LLC
1,329   Disposition at $29.6 per share. 39,338
12/13/2021 LSV CAPITAL MANAGEMENT LLC
299   Disposition at $28.37 per share. 8,482
12/13/2021 LSV CAPITAL MANAGEMENT LLC
2,196   Disposition at $28.37 per share. 62,300
12/13/2021 LSV CAPITAL MANAGEMENT LLC
1,296   Disposition at $27.49 per share. 35,627
12/13/2021 LSV CAPITAL MANAGEMENT LLC
286,496   Disposition at $27.49 per share. 7,875,775
12/13/2021 LSV CAPITAL MANAGEMENT LLC
2,339   Disposition at $26.48 per share. 61,936
12/13/2021 LSV CAPITAL MANAGEMENT LLC
17,169   Disposition at $26.48 per share. 454,635
12/13/2021 LSV CAPITAL MANAGEMENT LLC
1,627   Disposition at $25.29 per share. 41,146
12/13/2021 LSV CAPITAL MANAGEMENT LLC
11,945   Disposition at $25.29 per share. 302,089
12/10/2021 LSV CAPITAL MANAGEMENT LLC
12   Disposition at $32.16 per share. 385
12/10/2021 LSV CAPITAL MANAGEMENT LLC
88   Disposition at $32.16 per share. 2,830
12/10/2021 LSV CAPITAL MANAGEMENT LLC
2,172   Disposition at $31.55 per share. 68,526
12/10/2021 LSV CAPITAL MANAGEMENT LLC
15,942   Disposition at $31.55 per share. 502,970
12/10/2021 LSV CAPITAL MANAGEMENT LLC
967   Disposition at $30.77 per share. 29,754
12/10/2021 LSV CAPITAL MANAGEMENT LLC
7,093   Disposition at $30.77 per share. 218,251
12/10/2021 LSV CAPITAL MANAGEMENT LLC
12   Disposition at $32.16 per share. 385
12/10/2021 LSV CAPITAL MANAGEMENT LLC
88   Disposition at $32.16 per share. 2,830
12/10/2021 LSV CAPITAL MANAGEMENT LLC
2,172   Disposition at $31.55 per share. 68,526
12/10/2021 LSV CAPITAL MANAGEMENT LLC
15,942   Disposition at $31.55 per share. 502,970
12/10/2021 LSV CAPITAL MANAGEMENT LLC
967   Disposition at $30.77 per share. 29,754
12/10/2021 LSV CAPITAL MANAGEMENT LLC
7,093   Disposition at $30.77 per share. 218,251
12/09/2021 LSV CAPITAL MANAGEMENT LLC
1,911   Disposition at $32.73 per share. 62,547
12/09/2021 LSV CAPITAL MANAGEMENT LLC
14,028   Disposition at $32.73 per share. 459,136
12/09/2021 LSV CAPITAL MANAGEMENT LLC
5,751   Disposition at $32.06 per share. 184,377
12/09/2021 LSV CAPITAL MANAGEMENT LLC
42,203   Disposition at $32.06 per share. 1,353,028
12/09/2021 LSV CAPITAL MANAGEMENT LLC
1,560   Disposition at $31.08 per share. 48,484
12/09/2021 LSV CAPITAL MANAGEMENT LLC
11,452   Disposition at $31.08 per share. 355,928
12/09/2021 LSV CAPITAL MANAGEMENT LLC
1,911   Disposition at $32.73 per share. 62,547
12/09/2021 LSV CAPITAL MANAGEMENT LLC
14,028   Disposition at $32.73 per share. 459,136
12/09/2021 LSV CAPITAL MANAGEMENT LLC
5,751   Disposition at $32.06 per share. 184,377
12/09/2021 LSV CAPITAL MANAGEMENT LLC
42,203   Disposition at $32.06 per share. 1,353,028
12/09/2021 LSV CAPITAL MANAGEMENT LLC
1,560   Disposition at $31.08 per share. 48,484
12/09/2021 LSV CAPITAL MANAGEMENT LLC
11,452   Disposition at $31.08 per share. 355,928
12/08/2021 LSV CAPITAL MANAGEMENT LLC
208   Disposition at $33.8 per share. 7,030
12/08/2021 LSV CAPITAL MANAGEMENT LLC
1,531   Disposition at $33.8 per share. 51,747
12/08/2021 LSV CAPITAL MANAGEMENT LLC
4,883   Disposition at $33.23 per share. 162,262
12/08/2021 LSV CAPITAL MANAGEMENT LLC
35,836   Disposition at $33.23 per share. 1,190,830
12/08/2021 LSV CAPITAL MANAGEMENT LLC
208   Disposition at $33.8 per share. 7,030
12/08/2021 LSV CAPITAL MANAGEMENT LLC
1,531   Disposition at $33.8 per share. 51,747
12/08/2021 LSV CAPITAL MANAGEMENT LLC
4,883   Disposition at $33.23 per share. 162,262
12/08/2021 LSV CAPITAL MANAGEMENT LLC
35,836   Disposition at $33.23 per share. 1,190,830
11/22/2021 Sophia Randolph
Chief Medical Officer; Director 		14,884   Disposition at $36.77 per share. 547,284
11/22/2021 Sophia Randolph
Chief Medical Officer; Director 		30,000   Derivative/Non-derivative trans. at $4.08 per share. 122,400
10/18/2021 Peter S. García
Chief Financial Officer 		189   Disposition at $59.06 per share. 11,162
10/18/2021 Peter S. García
Chief Financial Officer 		438   Disposition at $58.3 per share. 25,535
10/18/2021 Peter S. García
Chief Financial Officer 		411   Disposition at $57.54 per share. 23,648
10/18/2021 Peter S. García
Chief Financial Officer 		1,437   Disposition at $56.09 per share. 80,601
10/18/2021 Peter S. García
Chief Financial Officer 		1,903   Disposition at $55.15 per share. 104,950
10/18/2021 Peter S. García
Chief Financial Officer 		2,851   Disposition at $54.33 per share. 154,894
10/18/2021 Peter S. García
Chief Financial Officer 		7,229   Derivative/Non-derivative trans. at $4.08 per share. 29,494
10/11/2021 Sophia Randolph
Chief Medical Officer; Director 		2,439   Disposition at $61.36 per share. 149,657
10/11/2021 Sophia Randolph
Chief Medical Officer; Director 		4,948   Disposition at $60.79 per share. 300,788
09/20/2021 Jaume Pons
President & CEO; Director 		235   Disposition at $76.46 per share. 17,968
09/20/2021 Jaume Pons
President & CEO; Director 		1,714   Disposition at $75.46 per share. 129,338
09/20/2021 Jaume Pons
President & CEO; Director 		10,322   Disposition at $74.42 per share. 768,163
09/20/2021 Jaume Pons
President & CEO; Director 		4,429   Disposition at $73.78 per share. 326,771
09/17/2021 Peter S. García
Chief Financial Officer 		1,100   Disposition at $81.19 per share. 89,309
09/17/2021 Peter S. García
Chief Financial Officer 		273   Disposition at $80.22 per share. 21,900
09/17/2021 Peter S. García
Chief Financial Officer 		1,746   Disposition at $79.46 per share. 138,737
09/17/2021 Peter S. García
Chief Financial Officer 		7,199   Disposition at $78.61 per share. 565,913
09/17/2021 Peter S. García
Chief Financial Officer 		1,027   Disposition at $77.84 per share. 79,941
09/17/2021 Peter S. García
Chief Financial Officer 		11,345   Derivative/Non-derivative trans. at $4.08 per share. 46,287
/news/latest/company/us/alxo

MarketWatch News on ALXO

  1. ALX Oncology initiated at buy with $106 target price at Stifel

    6:04 a.m. Sept. 30, 2021

    - Tonya Garcia

  2. ALX Oncology started at buy with $96 stock price target at UBS

    7:51 a.m. April 6, 2021

    - Tomi Kilgore

  3. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  4. ALX Oncology sets IPO terms, to raise up to $136 million

    7:29 a.m. July 13, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/alxo

Other News on ALXO

  1. New Strong Sell Stocks for January 19th

    6:23 a.m. Jan. 19, 2022

    - Zacks.com

  2. ALX Oncology plunges as director sells shares worth $75M

    2:31 p.m. Dec. 16, 2021

    - Seeking Alpha

  5. RENN, VIOT and IGMS among mid-day movers

    12:31 p.m. Dec. 13, 2021

    - Seeking Alpha

  7. ALX Oncology Holdings (ALXO) Investor Presentation

    1:21 p.m. Nov. 23, 2021

    - Seeking Alpha

  8. 10-Q: ALX ONCOLOGY HOLDINGS INC

    8:44 a.m. Nov. 12, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. Warning: ALXO is at high risk of performing badly

    4:52 a.m. Nov. 11, 2021

    - Seeking Alpha

  10. AGC, QUBT and BTB among mid-day movers

    12:48 p.m. Nov. 9, 2021

    - Seeking Alpha

  12. JP, HCDI and PETZ among mid-day movers

    12:48 p.m. Nov. 4, 2021

    - Seeking Alpha

  16. ALX Oncology Holdings (ALXO) Investor Presentation - Slideshow

    12:33 p.m. Oct. 7, 2021

    - Seeking Alpha

  17. ALX Oncology acquires ScalmiBio to expand pipeline

    6:37 a.m. Oct. 7, 2021

    - Seeking Alpha

  21. Loading more headlines...

At a Glance

ALX Oncology Holdings, Inc.

323 Allerton Avenue

South San Francisco, California 94080

Phone

1 6504667125

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

View SEC Filings

Revenue

$1.18M

Net Income

$-45.74M

Employees

23.00

Annual Report for ALXO

/news/pressrelease/company/us/alxo

Press Releases on ALXO

  16. Lightstone Ventures Raises $375 Million Fund

    6:00 a.m. Sept. 14, 2021

    - PR Newswire - PRF

  21. Loading more headlines...
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.